NYSEARCA:IHF
iShares US Healthcare Providers (IHF)
Financials 
Technical Analysis 
Aug 18, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
The iShares US Healthcare Providers ETF (IHF) has been firmly positioned as a top pick among analysts, primarily due to its strong holdings in notable companies like UnitedHealth and CVS. Key analysts, including Michael O'Reilly, have highlighted the attractive valuations and robust fundamentals that are driving interest in the healthcare provider sector, especially during times of market volatility. The general perspective is that these stocks function as defensive plays, which makes them appealing to investors looking for stability. With solid capital inflows throughout the year, IHF is recommended with a trailing stop increase to $52 and a target price of $68, reflecting a potential upside of approximately 18%. The ETF also offers a modest yield of 0.9%, adding to its appeal as a long-term investment option.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentIHF is a low-MER ETF holding a diversified portfolio of US healthcare providers such as Unitedhealth, CVS and Humana. It has had solid capital inflows all year. We recommend setting a stop-loss at $47, looking to achieve $65 -- upside potential of 18%. Yield 0.9%
A healthcare ETF? When it comes to healthcare ETF’s, a lot of them have a very large weighting in pharmaceuticals. A lot of the larger names have not done very well. This would be a good choice.
Stan WongIn the healthcare sector, this is one that he has been looking at. This will have the hospital names, some of the pharmacy benefit managers, etc. Has taken a bit of a run and is kind of scary to be buying it, but healthcare in this particular space, are the ones that are going to benefit the most.
Do medical stocks have seasonality? There are a couple of specialty healthcare ETFs that are just coming into their seasonal strength. One is iShares US Healthcare Providers (IHF-N) which has seasonal strength from now, right through until the end of January. The other is iShares US Medical Devices (IHI-N) with seasonal strength from the end of November until the middle of February. Both of these have very, very strong seasonality during that time.
- «
- ‹
- 1
- ›
- »
Popular Articles
iShares US Healthcare Providers (IHF) Frequently Asked Questions
What is iShares US Healthcare Providers stock symbol?
iShares US Healthcare Providers is a American stock, trading under the symbol IHF (previously IHF-N on Stockchase) on the NYSE Arca (IHF). It is usually referred to as AMEX:IHF or IHF
Is iShares US Healthcare Providers a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on IHF (previously IHF-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for iShares US Healthcare Providers.
Is iShares US Healthcare Providers a good investment or a top pick?
iShares US Healthcare Providers was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-07-28. Read the latest stock experts ratings for iShares US Healthcare Providers.
Why is iShares US Healthcare Providers stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for iShares US Healthcare Providers.
Is iShares US Healthcare Providers worth watching?
iShares US Healthcare Providers is covered by Stockchase experts and is worth watching.
What is iShares US Healthcare Providers stock price?
On 2026-08-18, iShares US Healthcare Providers (IHF) stock closed at a price of $56.74.
We reiterate IHF, with holdings like UnitedHealth and CVS, as a TOP PICK. Analysts comment healthcare provider stocks are rising due to attractive valuations, improving fundamentals, and defensive appeal amid market volatility. These are often viewed as defensive plays. We recommend trailing up the stop (from $47 to $52), looking to achieve $68 -- upside potential of 18%. Yield 0.9%